glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio The Multi-Sector Impacts of GLP-1RA

doi: 10.1530/EJE-09-0101

[DOI] [PMC free article] [PubMed] [Google Scholar] 84.Wang J., Liao B., Wang C., Zhong O., Lei X., Yang Y

Additional research showed that Rehmannia glutinosa use for 5 weeks improved impaired glucose tolerance, increased liver and muscle glycogen

Beyond its primary GLP-1 metabolic platform, SureNano Science is also evaluating early-stage opportunities that could expand the long-term scope of its therapeutic and delivery technology portfolio

14 In contrast, GLP-1 RAs have primarily been associated with gastrointestinal side effects and have demonstrated more favorable psychiatric and cardiovascular safety profiles

Borgmann D, Ciglieri E, Biglari N, Brandt C, Cremer AL, Backes H, et al